MindBio Therapeutics Introduces Voice-Based AI System for Workplace Impairment Detection

MindBio Therapeutics is commercializing a voice-based AI system to detect drug and alcohol impairment in seconds, initially targeting South American mining operations to enhance workplace safety.

Bay Area Metrowire Staff
Technology
MindBio Therapeutics Introduces Voice-Based AI System for Workplace Impairment Detection

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing workplace safety with a novel voice-based AI system designed to identify drug and alcohol impairment in seconds. The technology, which the company describes as the first of its kind in the world, analyzes acoustic patterns in speech to estimate intoxication levels, offering an alternative to traditional biological testing methods such as breathalyzers or laboratory samples. The platform is being developed for enterprise use, with a hardware kiosk system currently in preparation that can screen workers as they enter industrial facilities.

The initial focus is on the South American mining sector, where remote operations and heavy machinery make safety monitoring critical. According to a recent article discussing the technology, MindBio has spent several years conducting research into intoxication detection and has developed an AI prediction model that uses over 50 million data points to predict alcohol intoxication with remarkable accuracy. The company is commercializing the technology for enterprise environments including mining, aviation, construction, and law enforcement.

MindBio's approach leverages edge-AI kiosks that integrate bespoke hardware and software, enabling rapid, non-invasive screening. This could significantly reduce workplace accidents and liabilities associated with impairment, particularly in high-risk industries. The system's ability to provide results within seconds without requiring biological samples may improve compliance and efficiency in safety protocols.

For more details on the technology and its deployment, the full article is available at https://ibn.fm/ZPBcc. Additional updates and news regarding MindBio Therapeutics can be found in the company's newsroom at https://ibn.fm/MBQIF.

MindBio Therapeutics is a biotechnology company that is commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.

Blockchain Registration

QR Code for Blockchain Registration